EUVIMEDEUVIMED entdecken
Crossref

Reduction of D2 receptors on microglia leads to ZBP1-mediated PANoptosis of mPFC in Parkinson's disease depression mice

Qiyue Zhao, Xinyao Zhang, Jing Zhang, Ying Zhang, Lu Jia, Sijia Guo, Mengqing Zhang, Haoran Wang, Yuling Wang, Yue Guan, Yi Zhang, Suibing Miao und 2 weitere

International Immunopharmacology · 2025-06 · 158 · 114809

DOI: 10.1016/j.intimp.2025.114809 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2025-06. Verfasst von Qiyue Zhao und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Hebei Medical University, Shijiazhuang, Hebei, China. Hauptthemen laut MEDLINE: Parkinson Disease, Depression, Neuroinflammatory Diseases, RNA-Binding Proteins. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Ministry of Education of the People's Republic of China, Hebei Provincial Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Parkinson's disease depression (PDD) is a common non-motor symptom of Parkinson's disease (PD), characterized by complex neurobiological mechanisms that remain poorly understood. This study identifies ZBP1-mediated PANoptosis as a critical mechanism linking neuroinflammation, neuronal loss, and depressive behaviors in PDD. Using a 6-hydroxydopamine (6-OHDA)-induced PDD mouse model, we observed significant reductions in dopaminergic projections from the substantia nigra (SN) to the medial prefrontal cortex (mPFC), accompanied by neuronal loss and depressive-like behaviors. Microglial activation, driven by DRD2 downregulation, was found to impair mPFC neuronal function, as evidenced by altered local field potentials and reduced gamma, beta, and theta oscillations. Furthermore, ZBP1 expression was significantly upregulated in the mPFC of PDD mice, where it colocalized with CaMKII-positive neurons and facilitated the formation of PANoptosomes, a multimeric complex driving pyroptosis, apoptosis, and necroptosis. Knockdown of ZBP1 in the mPFC effectively suppressed PANoptosome formation, reduced neuronal injury, restored local field potentials, and alleviated depressive-like behaviors. These findings highlight ZBP1-mediated PANoptosis as a key pathological mechanism in PDD and suggest that targeting ZBP1 may represent a promising therapeutic strategy for mitigating neuronal loss and depressive symptoms in PDD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseDepressionNeuroinflammatory DiseasesRNA-Binding ProteinsRegulated Cell DeathReceptors, Dopamine D2Behavior, AnimalOxidopamineDisease Models, AnimalSubstantia NigraDopaminergic NeuronsPrefrontal CortexNeural PathwaysGene Expression RegulationGene Knockdown TechniquesMaleAnimalsMiceMice, Inbred C57BL

Stichwörter der Autor:innen

Dopamine D2 receptor (DRD2)Medial prefrontal cortex (mPFC)MicrogliaPANoptosisParkinson's disease depression (PDD)Z-DNA binding protein 1 (ZBP1)

Substanzen

OxidopamineZbp1 protein, mouseRNA-Binding ProteinsReceptors, Dopamine D2DRD2 protein, mouse

Autor:innen und Institutionen

  • Department of Physiology, Hebei Medical University, Shijiazhuang, Hebei, China.
  • Department of Neurology, the Third Hospital of Hebei Medical University, Shijiazhuang, China.
  • Department of Physiology, Hebei Medical University, Shijiazhuang, Hebei, China; Key Laboratory of Neurophysiology of Hebei Province, Shijiazhuang, China.
  • Institute of Reproductive Medicine of Shijiazhuang, The Fourth Hospital of Shijiazhuang, Gynecology and Obstetrics Hospital Affiliated to Hebei Medical University, Shijiazhuang, China.
  • Department of Physiology and Pathophysiology, School of Basic Medical Science, Capital Medical University, No. 10 Xitoutiao, You An Men, Beijing, China.
  • Department of Physiology, Hebei Medical University, Shijiazhuang, Hebei, China; Key Laboratory of Neurophysiology of Hebei Province, Shijiazhuang, China; The Key Laboratory of Neural and Vascular Biology, Ministry of Ed…

Förderung

  • Ministry of Education of the People's Republic of China
  • Hebei Provincial Natural Science Foundation

Zitieren

APA

Zhao, Q., Zhang, X., Zhang, J., Zhang, Y., Jia, L., Guo, S., Zhang, M., Wang, H., Wang, Y., Guan, Y., Zhang, Y., Miao, S., Zhu, J. X., & Ma, H. (2025). Reduction of D2 receptors on microglia leads to ZBP1-mediated PANoptosis of mPFC in Parkinson's disease depression mice. International Immunopharmacology, 158, 114809. https://doi.org/10.1016/j.intimp.2025.114809

Vancouver

Zhao Q, Zhang X, Zhang J, Zhang Y, Jia L, Guo S, et al. Reduction of D2 receptors on microglia leads to ZBP1-mediated PANoptosis of mPFC in Parkinson's disease depression mice. International Immunopharmacology. 2025;158:114809. doi:10.1016/j.intimp.2025.114809

BibTeX
@article{Zhao2025,
  author = {Zhao, Qiyue and Zhang, Xinyao and Zhang, Jing and Zhang, Ying and Jia, Lu and Guo, Sijia and Zhang, Mengqing and Wang, Haoran and Wang, Yuling and Guan, Yue and Zhang, Yi and Miao, Suibing and Zhu, Jin-Xia and Ma, Huijie},
  title = {Reduction of D2 receptors on microglia leads to ZBP1-mediated PANoptosis of mPFC in Parkinson's disease depression mice},
  journal = {International Immunopharmacology},
  year = {2025},
  volume = {158},
  pages = {114809},
  doi = {10.1016/j.intimp.2025.114809}
}
Kostenlos starten →